Skip to main content

Genetic and histopathological analysis of transverse testicular ectopia without persistent Müllerian duct syndrome: two case reports



Transverse testicular ectopia (TTE) is a rare anomaly in which both testes descend through a single inguinal canal into the same hemiscrotum. Although almost 20–50% of patients with TTE exhibit persistent Müllerian duct syndrome (PMDS) and many genetic analyses have been performed, no reports have described the genes contributing to TTE without PMDS. Here, we report two cases of TTE without PMDS using immunohistochemical staining and genetic analysis.

Case presentation

Two Asian patients with TTE without PMDS were subjected to orchiopexy. We performed testicular biopsies during operation and obtained blood samples before the operation. Testicular tissues were stained for c-kit, placental alkaline phosphatase (PLAP), and undifferentiated embryonic cell transcription factor 1 (UTF1) to evaluate the presence of intratubular malignant germ cells. Additionally, we performed polymerase chain reaction-based direct sequencing to identify single nucleotide polymorphisms in genes associated with regression of the Müllerian duct and testicular descent (that is, anti-Müllerian hormone [AMH], AMH receptor 2 [AMHR2], insulin-like 3 [INSL3], and relaxin family peptide receptor 2 [RXFP2]). The three-dimensional structures of proteins were predicted using SWISS-MODEL. In immunohistochemical analysis, c-kit and UTF1 were positive, whereas PLAP was negative in three testicular tissue samples from the two patients. These features were also detected on the unaffected side. In variant analysis, common missense variants in the AMH gene (g.365G>T; c.165G>T; p.Ser49Ile [rs10407022]) were observed. All variants in INSL3 and RXFP2 genes were intronic or silent.


Because UTF1, a specific marker of spermatogonial stem cell activity, was expressed in both the affected and unaffected sides in the testicular tissues of two patients, the risk of malignancy may be high in these patients. Although the etiology of TTE without PMDS remains unclear, our variant analysis results were consistent with previous reports, and variants in the AMH gene (rs10407022) may contribute to the specific phenotype of TTE without PMDS.

Peer Review reports


Ectopic testis is a congenital anomaly in which testes are located outside of the normal path of descent, that is, in the superficial inguinal pouch, supurapubic region, femoral region, base of penis, or opposite side of hemiscrotum [1]. Transverse testicular ectopia (TTE) is a rare anomaly in which both testes descend through a single inguinal canal into the same hemiscrotum. In the absence of testicular tumors, the treatment for TTE is orchiopexy. However, patients with TTE have a higher risk of testicular tumors and cryptorchidism; indeed, the incidence of testicular tumors in patients with TTE is 18% [2], which is higher than that observed in patients with isolated cryptorchidism.

The pathogenesis of TTE involves persistent Müllerian ducts, fusion of the vas deferens, and primary gubernacular defects. Approximately 20–50% of patients with TTE also exhibit persistent Müllerian duct syndrome (PMDS), which is strongly associated with TTE [3,4,5]. The etiology of PMDS is explained by inadequate Müllerian suppression of Müllerian ducts owing to the glycoprotein anti-Müllerian hormone (AMH). Specific variants in the genes encoding AMH and its receptor AMHR2 have been reported in patients with PMDS [6]. Although AMH and AMHR2 have been reported to be responsible for PMDS, no reports have described the genes contributing to TTE without PMDS. However, some authors have described relationships between anomalies in the gubernaculum, that is, congenital fascial bands [7] and anomalous distal insertion [8].

Various processes are involved in descent of the testes, and insulin-like 3 (INSL3) protein is known to play a role in descent of the testes in the transabdominal phase and growth of the gubernaculum [9]. INSL3 is a member of the insulin-like hormone family and is exclusively synthesized in the gonads. INSL3 and its receptor relaxin family peptide receptor 2 (RXFP2) play important roles in descent of the testes during the transabdominal phase, and single-nucleotide polymorphisms in the INSL3 and RXFP2 genes are risk factors for cryptorchidism [10].

Despite these previous studies, few reports have described the histology or genetics of TTE, likely because of the very low incidence of this condition. Here, we report two cases of TTE without PMDS. We investigated their testicular histology and genetic alterations in the AMH, AMHR2, INSL3, and RXFP2 genes to elucidate the pathological features and genetic etiology of the testes in these patients using immunohistochemistry and direct sequencing analyses.

Case presentation

Case 1

This Asian patient was naturally delivered at 39 weeks, 0 days via normal labor and had no siblings. The birth weight was 2426 g, and Apgar scores were 9(1′) and 9(5′). At birth, the baby was diagnosed with bilateral nonpalpable testes and hypospadias. Chromosomal and genetic tests showed that the karyotype was 46,XY and that the SRY gene was positive. Thus, the baby was brought up as a boy. At 4 months old, his right testis was palpable in his right scrotum. Because his left testis was still nonpalpable, he was referred to our hospital. Ultrasonography and magnetic resonance imaging (MRI) revealed that left testis was located around his right groin (Fig. 1). Thus, we diagnosed TTE and performed laparoscopic left orchiopexy at 15 months of age. Preoperative serum hormone levels are shown in Table 1.

Fig. 1

Appearance of external genitalia and MRI findings in cases 1 and 2. Dotted circles indicate palpable testes

Table 1 Patients’ characteristics at surgery

According to our previous report [11], conventional laparoscopy uncovers the left abdominal testis just above the right internal ring. The right processus vaginalis was opened. We could not confirm the existence of any Müllerian duct derivatives. After sufficient mobilization, the left testis was delivered into the subdartos pouch of the left scrotum. The left testis was fixed in the scrotum using a 5–0 polyglactin suture, and at that time, testicular biopsy was also performed with permission from the patient’s parents. Subsequently, at 22 months old, we performed repair of hypospadias. There were no postoperative complications, and both testes were located in the lower scrotum. Both testes were palpable in their respective scrotums without testicular ascent or atrophy at 8 years postoperatively.

Case 2

This patient was born at 39 weeks, 3 days via spontaneous delivery. The Asian patient had no siblings, and the birth weight was 3306 g. At 1 month of age, he was found to lack testis in the right scrotum during a medical checkup. He was followed up by a practicing physician, but then referred to our hospital because of spontaneous descent of the right testis at 18 months of age; his left testis was located in his right scrotum, and a small mass was palpable in his left groin. MRI revealed that the right testis was located around his left lower abdomen (Fig. 1), and he was then diagnosed with TTE. His karyotype was 46,XY, and he was positive for the SRY gene. Endocrinological examination revealed that all parameters were within normal limits as appropriate for his age.

First, we performed conventional laparoscopy, and the right abdominal testis was detected just above the left internal ring with left patent processus vaginalis. The bilateral vas deferens and spermatic vessels ran toward the left internal ring and left testis without Müllerian duct derivatives. Although we attempted to fix his right testes via the right groin into the right scrotum, right orchiopexy with a transseptal approach [12] was required to avoid injury to the vas deferens and vessels. Both testes were palpable in their respective scrotums without testicular ascent or atrophy at 5 years postoperatively. The characteristics of the two patients at surgery are shown in Table 1.

To evaluate the histopathology of their testes and genetic etiology in these patients with TTE, we performed immunohistological examination and gene variant analysis. We obtained informed consent from the two patients’ families for participation in sample collection and analysis. We performed testicular biopsy during surgery and obtained three testicular tissues (left testis from case 1; bilateral testes from case 2). The tissues were fixed in 4% paraformaldehyde for histological examination. Blood samples were also collected prior to operation for gene analysis. Studies using human testicular tissue and genomic DNA were approved by the institutional review board of Nagoya City University Hospital (approved number: 84).

Testicular tissues fixed in 4% paraformaldehyde were embedded in paraffin and sectioned at 5 μm thickness. Histopathological examination of hematoxylin-eosin staining and immunohistochemical analysis were performed using serial sections. Signals were detected using anti-c-Kit antibodies (1:500; catalog no. A4502; Dako, Tokyo, Japan), anti-placental alkaline phosphatase (PLAP) antibodies (1:50; catalog no. M7191; Dako), and anti-undifferentiated embryonic cell transcription factor 1 (UTF1) antibodies (1:1000; catalog no. MAB4337; Merck Millipore, Darmstadt, Germany), as described previously [13]. Briefly, after blocking nonspecific binding with 5% skim milk in phosphate-buffered saline, 5-μm-thick sections were incubated overnight at 4 °C. Signals were detected with an avidin-biotinylated enzyme complex system, using a VECTASTAIN ABC Kit (Vector Laboratories, Burlingame, CA, USA) and anti-rabbit IgG (catalog no. PK-6101; Vector Laboratories), according to the manufacturer’s instructions.

Genomic DNA was extracted from leukocytes isolated from patient’s peripheral blood using a Wizard genomic DNA purification kit (Promega, Madison, WI, USA), according to the manufacturer’s instructions, as previously reported [14]. The purity of the extracted DNA was determined by measurement of absorbance and evaluation of gel electrophoresis results. The primers for amplification were designed based on the specific deoxyribonucleic acid (DNA) sequences (Additional file 1). Amplification of exons was performed by PCR using sequence-specific primers. PCR products were sequenced using an ABI BigDye Terminator ver3.1 Cycle Sequencing Kit (Thermo Fisher Scientific, Waltham City, MA, USA) with an ABI 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA) based on the primer sets used for sequencing (Additional file 2). Variants were identified by comparisons with RefSeq in the NCBI database ( The three-dimensional structures of proteins were predicted using SWISS-MODEL (

Immunohistochemical staining of testicular tissue is shown in Fig. 2. In three samples from the two patients, c-kit was positive, whereas PLAP was negative. Thus, a definitive diagnosis of intratubular malignant germ cells could not be made. UTF1, a marker of undifferentiated spermatogonial stem cells, was positive in these samples, even in the testes of the unaffected side in case 2. The results of PCR-based direct sequencing of AMH, AMHR2, INSL3, and RXFP2 are shown in Table 2. We observed common variants in two cases. The common variants in the AMH gene were g.365G>T and g.1416G>A; g.365G>T was a missense variant in exon 1 (c.165G>T), changing Ser to Ile (p.Ser49Ile; Fig. 3), and g.1416G>A was present in intron 2. With respect to g.365G>T (c.165G>T; p.Ser49Ile) in the AMH gene, protein structure prediction by Swiss-Model indicated that the loop structure was altered (Fig. 4). There were no common variants in the AMHR2 gene. A common variant, g.4983G>A, was observed in the INSL3 gene; however, this variant was within an untranslated region. In the RXFP2 gene, eight common variants were observed in the intronic region and in the 3′ untranslated region, and one variant was observed in exon 12 (g.46869A>G; c.963A>G). The variant in exon 12 was a nonsense variant.

Table 2 Genetic variants in AMH, AMHR2, INSL3, and RXFP2
Fig. 2

Immunohistochemical staining of testicular tissues from the two cases. In case 2, testicular biopsy of the unaffected side was performed after obtaining approval from the patient’s parents. Notably, c-kit and UTF1 were positive in spermatogonia and spermatocytes in all samples, whereas PLAP was negative. H-E: hematoxylin-eosin, c-kid, PLAP: placental alkaline phosphatase, UTF1: undifferentiated embryonic cell transcription factor 1. Scale bar: 30 μm

Fig. 3

Partial chromatograms the AMH gene variant in cases 1 and 2. The base change g.365G > T led to the missense variant in exon 1

Fig. 4

Three-dimensional prediction of AMH protein by SWISS-MODEL. Protein models of AMH 49Ser a and AMH 49Ile b are shown. The change in loop structure is shown (arrow)

Discussion and conclusions

We reported two cases of TTE without PMDS. Furthermore, we suggested the tumor risk of the patients with TTE and necessity of long-term follow-up for both testes based on genetic and histopathological analysis. To our knowledge, this is the first report regarding genetic and histopathological features focused on TTE without PMDS.

TTE is a rare form of testicular ectopia in both testes existing in the same side of the hemiscrotum. Since the first case was reported by Von Lenhossek in 1886, more than 260 cases have been reported in the English literature [12]. According to previous reports [15, 16], the standard treatment is orchiopexy; when accompanied by testicular tumors, orchiectomy is performed. TTE is accompanied by various abnormalities, such as PMDS, inguinal hernia, and hypospadias. Here we reported two cases of TTE without PMDS and identified common pathological features in their testes, including positivity for c-kit and the presence of UTF1-positive germ cells. Notably, these features were also detected on the unaffected side. Additionally, we identified a common missense variant in the exonic region of the AMH gene (g.365G>T; c.165G>T [rs10407022]), providing important insights into the genetic basis of TTE.

The incidence of testicular tumors in patients with TTE is 18% [2], which is equivalent to that of patients with abdominal testes and higher than that in healthy individuals and patients with inguinal testes. In this study, we evaluated whether our cases exhibited intratubular malignant germ cells by immunohistochemical staining of testicular tissue. Notably, both cases were positive for c-kit, negative for PLAP, and positive for UTF1, a specific marker of spermatogonial stem cell activity [17] that can be used to diagnose testicular tumors [18]. Thus, we identified undifferentiated spermatogonial stem cells in the testis of patients with TTE. Interestingly, both affected and unaffected testes were positive for UTF1 in case 2. Thus, we assumed that testicular tumors may appear in the contralateral testis in the future. To the best of our knowledge, this is the first report to consider the possibility of malignancy in the testes of patients with TTE by immunohistochemical staining.

Concerning the etiology of TTE, several hypotheses have been proposed, as follows, including defective implantation of the gubernaculum, obstruction of the inguinal ring, adherence and fusion of the developing Wolffian ducts, and existence of derivatives from the Müllerian duct (PMDS) [15]. Although many reports have described genetic variations in TTE with PMDS [19, 20], few studies have reported TTE without PMDS. Testicular descent is a stepwise process that involves various genes. Zimmermann et al. [21] reported that complete loss of gubernacular attachment, transverse ectopia, and/or torsion were observed in transgenic mice null for Insl3 and that INSL3 regulated gubernaculum development through its receptor, RXFP2, during the transabdominal descent of the testes [9]. In the current study, we investigated gene variants associated with testicular descent (INSL3 and RXFP2), but only one silent variant (RXFP2 c.963A>G) was observed among two patients, and the other variants were within the intronic region. Because INSL3 (1.8%) and RXFP2 (2.9%) gene variants are rarely observed in idiopathic cryptorchidism [22] and there are no reports of these gene variants in TTE, it is likely that these gene variants are not associated with development of TTE.

On the basis of the presence of various associated anomalies, TTE can be classified into three types [23]: type 1, accompanied by hernia; type 2, accompanied by PMDS; type 3 associated with hypospadias, scrotal abnormalities, fused vas deferens, or testicular microlithiasis [15]. According to this classification, case 1 was type 1, and case 2 was type 3 TTE. Almost 20–50% of patients with TTE exhibit PMDS [2], and some reports have suggested that PMDS is involved in the pathogenesis of TTE. As reviewed by Picard et al. [20], several variants in the AMH and AMHR2 genes have been reported in patients with TTE with PMDS [6, 19]. AMH is responsible for the regression of Müllerian ducts in male fetuses, and variants inactivating AMH or its receptor AMHR2 lead to PMDS. Although the cases in the current report were TTE without PMDS, a common variant in the AMH gene was observed, including the missense variant g.365G>T (c.165G>T; p.Ser49Ile). These findings suggested that abnormalities other than PMDS, for exampe, fused vas deferens, may be associated with variants in the AMH gene.

The identified variant (AMH c.165G>T; rs10407022) is known to be related to polycystic ovary syndrome (PCOS) [24]. Additionally, this variant has been shown to be associated with reduced incidence of PCOS and lower follicle numbers in women with PCOS. Kevenaar et al. also investigated the roles of the AMH signaling pathway in the pathophysiology of PCOS using a genetic approach [25]. They showed that the AMH Ile49Ser polymorphism, which was the same as the variant identified in the current study, contributes to the severity of the PCOS phenotypes. Moreover, they confirmed that the bioactivity of the AMH 49Ser protein was diminished compared with that of the AMH 49Ile protein using an in vitro study [25]. Although the relationship between TTE and PCOS is still unclear, these conditions are similar in that they are both characterized by abnormal gonadal morphology. More recently, Greiber et al. reported that the AMH genotype (rs10407022 T>G) is associated with higher serum AMH levels in prepubertal Danish boys [26]. The TT allele in our current two cases suggested that serum AMH levels may be lower compared with that in healthy boys. Although the spot concentration of serum AMH was normal in case 1, it was higher than that in age-matched healthy individuals in case 2 [27]. Thus, these findings may reflect negative feedback caused by lower AMH levels. As described above, we could not rule out that AMH gene variation could lead to a specific phenotype, TTE without PMDS, in the current cases. However, the number of cases was small, and further functional studies are needed to confirm these findings.

In conclusion, we reported two cases of TTE without PMDS and described the histological, immunological, and genetic features from these cases. Our findings suggested that patients with TTE may be at higher risk of testicular tumors on both the affected and unaffected sides. Thus, physicians should be careful to monitor this possibility in both testes. Although the etiology remains unclear, common missense variants in the AMH gene (g.365G>T; c.165G>T [rs10407022]) may affect the development of TTE without PMDS. Further studies with more patients are warranted.

Availability of data and materials

The datasets generated during the current study are not publicly available because it is possible that individual privacy could be compromised.



Anti-Müllerian hormone


Anti-Müllerian hormone receptor type 2


Insulin-like peptide 3


Polymerase chain reaction


Placental alkaline phosphatase


Persistent Müllerian duct syndrome


Relaxin/insulin-like family peptide receptor 2


Transverse testicular ectopia


Undifferentiated embryonic cell transcription factor 1


  1. 1.

    Shamsuddin S, Mirza TH, Khan N, Ibrahim M, Imtiaz T. Transverse testicular ectopia. J Ayub Med Coll Abbottabad. 2007;19(1):56–7.

    PubMed  Google Scholar 

  2. 2.

    Berkmen F. Persistent Müllerian duct syndrome with or without transverse testicular ectopia and testis tumours. Br J Urol. 1997;79(1):122–6.

    CAS  Article  Google Scholar 

  3. 3.

    De Luna AM, Ortenberg J, Craver RD. Exploration for testicular remnants: implications of residual seminiferous tubules and crossed testicular ectopia. J Urol. 2003;169(4):1486–9.

    Article  Google Scholar 

  4. 4.

    Wuerstle M, Lesser T, Hurwitz R, Applebaum H, Lee SL. Persistent mullerian duct syndrome and transverse testicular ectopia: embryology, presentation, and management. J Pediatr Surg. 2007;42(12):2116–9.

    Article  Google Scholar 

  5. 5.

    Thambidorai CR, Khaleed A. Transverse testicular ectopia: correlation of embryology with laparoscopic findings. Pediatr Surg Int. 2008;24(3):371–4.

    CAS  Article  Google Scholar 

  6. 6.

    Belville C, Maréchal JD, Pennetier S, Carmillo P, Masgrau L, Messika-Zeitoun L, et al. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Hum Mol Genet. 2009;18(16):3002–13.

    CAS  Article  Google Scholar 

  7. 7.

    Ramareddy RS, Alladi A, Siddappa OS. Ectopic testis in children: experience with seven cases. J Pediatr Surg. 2013;48(3):538–41.

    Article  Google Scholar 

  8. 8.

    Luo CC. A variant presentation of transverse testicular ectopia due to abnormal insertion of the gubernaculum. Eur J Pediatr. 2004;163(12):751–2.

    Article  Google Scholar 

  9. 9.

    Hutson JM, Thorup JM, Beasley SW. Transabdominal migration of the testis. In: Descent of the Testis. 2nd ed. Switzerland: Springer International Publishing; 2016. p. 17–28.

  10. 10.

    Kojima Y, Mizuno K, Kohri K, Hayashi Y. Advances in molecular genetics of cryptorchidism. Urology. 2009;74(3):571–8.

    Article  Google Scholar 

  11. 11.

    Kojima Y, Mizuno K, Kamisawa H, Kato T, Kohri K, Hayashi Y. Laparoscopic management of nonpalpable testis: new treatment strategy. J Endourol. 2011;25(4):635–40.

    Article  Google Scholar 

  12. 12.

    Abdullayev T, Korkmaz M. Transvers testicular ectopia: a case report and literature review. Int J Surg Case Rep. 2019;65:361–4.

    Article  Google Scholar 

  13. 13.

    Mizuno K, Hayashi Y, Kamisawa H, Nishio H, Moritoki Y, Kohri K. Expression analysis of the pluripotency marker UTF-1 for determining the applicability of testis-sparing surgery for prepubertal testis tumors. J Pediatr Surg Case Rep. 2013;1(6):125–8.

    Article  Google Scholar 

  14. 14.

    Mizuno K, Kojima Y, Kamisawa H, Moritoki Y, Nishio H, Nakane A, et al. Elucidation of distinctive genomic DNA structures in patients with 46, XX testicular disorders of sex development using genome-wide analyses. J Urol. 2014;192:535–41.

    CAS  Article  Google Scholar 

  15. 15.

    Raj V, Redkar R, Krishna S, Tewari S. Rare case of transverse testicular ectopia—case report and review of literature. Int J Surg Case Rep. 2017;41:407–10.

    Article  Google Scholar 

  16. 16.

    Bascuna R Jr, Ha JY, Lee YS, Lee HY, Im YJ, Han SW. Transverse testis ectopia: diagnostic and management algorithm. Int J Urol. 2015;22(3):330–1.

    Article  Google Scholar 

  17. 17.

    Kamisawa H, Kojima Y, Mizuno K, Imura M, Hayashi Y, Kohri K. Attenuation of spermatogonial stem cell activity in cryptorchid testes. J Urol. 2012;187(3):1047–52.

    Article  Google Scholar 

  18. 18.

    Wang P, Li J, Allan RW, Guo CC, Peng Y, Cao D. Expression of UTF1 in primary and metastatic testicular germ cell tumors. Am J Clin Pathol. 2010;134(4):604–12.

    Article  Google Scholar 

  19. 19.

    Nishi MY, Domenice S, Maciel-Guerra AT, Zaba Neto A, Silva MA, Costa EM, et al. Analysis of anti-Mullerian hormone (AMH) and its receptor (AMHR2) genes in patients with persistent Mullerian duct syndrome. Arq Bras Endocrinol Metabol. 2012;56(8):473–8.

    Article  Google Scholar 

  20. 20.

    Picard JY, Cate RL, Racine C, Josso N. The persistent Müllerian duct syndrome: an update based upon a personal experience of 157 cases. Sex Dev. 2017;11(3):109–25.

    Article  Google Scholar 

  21. 21.

    Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol. 1999;13(5):681–91.

    CAS  Article  Google Scholar 

  22. 22.

    Bay K, Main KM, Toppari J, Skakkebaek NE. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat Rev Urol. 2011;8(4):187–96.

    CAS  Article  Google Scholar 

  23. 23.

    Gauderer MW, Grisoni ER, Stellato TA, Ponsky JL, Izant RJ Jr. Transverse testicular ectopia. J Pediatr Surg. 1982;17(1):43–7.

    CAS  Article  Google Scholar 

  24. 24.

    Xu P, Shen SM, Zhang XL, Liang F, Xie GB, Yi L, et al. Haplotype analysis of single nucleotide polymorphisms in anti-Müllerian hormone gene in Chinese PCOS women. Arch Gynecol Obstet. 2013;288(1):125–30.

    CAS  Article  Google Scholar 

  25. 25.

    Kevenaar ME, Laven JS, Fong SL, Uitterlinden AG, de Jong FH, Themmen AP, et al. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metab. 2008;93(4):1310–6.

    CAS  Article  Google Scholar 

  26. 26.

    Greiber IK, Hagen CP, Busch AS, Mieritz MG, Aksglæde L, Main K, et al. The AMH genotype (rs10407022 T>G) is associated with circulating AMH levels in boys, but not in girls. Endocr Connect. 2018;7(2):347–54.

    CAS  Article  Google Scholar 

  27. 27.

    Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, et al. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab. 2010;95(12):5357–64.

    CAS  Article  Google Scholar 

Download references




All authors received no financial support for the research, authorship, and/or publication of this article.

Author information




TN, KM, HN, AN, and YH were in charge of medical care for the patients. This study was designed by KM. KM, HN, and YH extracted genomic DNA from patients’ peripheral blood and managed testicular tissue samples. TN and MU performed data mining and analysis. TN drafted the manuscript, and KM, HN, TK, DM, SK, HK, and TM supported manuscript preparation. KM performed critical literature review and revised the manuscript. TY and YH supervised this study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kentaro Mizuno.

Ethics declarations

Ethics approval and consent to participate

The patients’ parents provided written informed consent, and this study was approved by the Institutional Review Board of Nagoya City University (approval no. 84).

Consent for publication

Written informed consent was obtained from the patients’ legal guardians for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

There are no potential conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

Primer set used for ploymerase chain reaction (PCR)

Additional file 2.

Primer set used for sequencing

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nagai, T., Mizuno, K., Usami, M. et al. Genetic and histopathological analysis of transverse testicular ectopia without persistent Müllerian duct syndrome: two case reports. J Med Case Reports 14, 233 (2020).

Download citation


  • Transverse testicular ectopia
  • Anti-Müllerian hormone
  • Persistent Müllerian duct syndrome